Stock LIGAND PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Ligand Pharmaceuticals Inc. OTC Bulletin Board

Equities

US53220K1815

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Ligand Pharmaceuticals Inc.
Jul. 01 Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) added to Russell 2000 Defensive Index CI
Jul. 01 Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) dropped from Russell 3000 Growth Index CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) added to Russell 2000 Defensive Index
CI
Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) dropped from Russell 3000 Growth Index
CI
Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) added to Russell 2000 Value-Defensive Index
CI
Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) dropped from Russell 3000E Growth Index
CI
Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) dropped from Russell 2000 Growth Index
CI
Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) dropped from Russell 2500 Growth Index
CI
Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) dropped from Russell Small Cap Comp Growth Index
CI
Ligand Partner Verona Pharma Announces FDA Approval of Ohtuvayre, First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years
AQ
Ligand Pharmaceuticals' Partner Gets US FDA Approval for Ohtuvayre to Treat Chronic Obstructive Pulmonary Disease
MT
Ligand Partner Verona Pharma Announces FDA Approval of Ohtuvayre™ (ensifentrine), First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years
BU
Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE for Adults
AQ
Merck Receives FDA Approval for Capvaxive, Triggers $2 Million Payment for Ligand Pharmaceuticals
MT
Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults
BU
Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE? (Pneumococcal 21-valent Conjugate Vaccine) for Adults
CI
Ligand Pharmaceuticals Incorporated : First Quarter 2024 Presentation
PU
Ligand to Participate in Upcoming Investor Conferences
BU
Ligand Pharmaceuticals Insider Sold Shares Worth $830,449, According to a Recent SEC Filing
MT
Sector Update: Health Care Stocks Softer Late Afternoon
MT
Ligand Pharmaceuticals Shares Rise After Q1 Adjusted Earnings, Revenue Beat Views
MT
Ligand: Q1 Earnings Snapshot
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LGND Stock
  4. Stock
  5. News Ligand Pharmaceuticals Inc.